Healthcare Sales & Marketing Network News: hepatitis C virus

Searching News Database: hepatitis C virus

HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch

HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 19 Mar 2019
Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Diagnostics Regulatory

HSMN NewsFeed - 21 Sep 2018
CHMP Recommends Approval of Buvidal(R) (CAM2038) for the Treatment of Opioid Dependence
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Jul 2018
SeraCare Announces the Expansion of Their Proprietary AccuPlex(TM) Technology Product Portfolio with the Launch of the AccuSpan(TM) HCV RNA Linearity Panel
Diagnostics Product Launch

HSMN NewsFeed - 27 Jun 2018
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Treatment of Autoimmune Hepatitis
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jun 2018
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Diagnostics FDA

HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jan 2018
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Diagnostics FDA

HSMN NewsFeed - 4 Jan 2018
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Jun 2017
AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jun 2017
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
Diagnostics FDA

HSMN NewsFeed - 16 Jun 2017
New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Biopharmaceuticals

HSMN NewsFeed - 21 Apr 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 7 Apr 2017
FDA Approves Two Hepatitis C Drugs for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Feb 2017
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
Diagnostics FDA

HSMN NewsFeed - 3 Jan 2017
Ascletis Raises US$100 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Dec 2016
AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Oct 2016
First Patient in Malaysia Receives TheraSphere(TM) Radioembolization Therapy
Devices Oncology

HSMN NewsFeed - 23 Sep 2016
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 26 Jul 2016
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR(TM) (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jul 2016
CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Jun 2016
Regulus Secures $30 Million Growth Capital Credit Facility
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 15 Apr 2016
AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2016
AbbVie Announces Real-World Data with VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA(R) (dasabuvir tablets) from Large German Hepatitis C-Registry
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA

HSMN NewsFeed - 29 Jan 2016
Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 14 Dec 2015
Enanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2015
AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval in Japan for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2015
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Jan 2015
Debiopharm Group(TM) Regains Full Rights to Alisporivir Program
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2014
European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Jun 2014
Bristol-Myers Squibb Receives Positive CHMP Opinion for Daklinza(R) (daclatasvir) for Treatment of Chronic Hepatitis C in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Jun 2014
Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2014
Gilead’s Sovaldi(R) Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2014
Gilead Announces Results from Study of Sovaldi(R) for Retreatment of Chronic Hepatitis C in Patients Not Cured with Prior Antiviral Therapy
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2014
Aethlon Medical (AEMD) Note: U.S. Clinical Progression
Devices

HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Feb 2014
Regulus Appoints Head of Regulus microMarkers(TM) R&D Division
Biopharmaceuticlas Personnel

HSMN NewsFeed - 4 Feb 2014
Regulus Strengthens Executive Management Team with Addition of David Szekeres as Chief Business Officer and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2014
European Commission Grants Marketing Authorization for Gilead’s Sovaldi(R) (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Jan 2014
Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2014
Idenix Pharmaceuticals Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2013
U.S. Food and Drug Administration Approves Gilead’s Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Dec 2013
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Biopharmaceuticals Litigation

HSMN NewsFeed - 20 Nov 2013
Vertex Sells INCIVO(R) Product Royalty Rights for $152 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Diagnostics Personnel

HSMN NewsFeed - 21 Jun 2013
3-V Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Jun 2013
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Mar 2013
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2012
Biota Pharmaceuticals Announces Appointment of New Executive Officers
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2012
BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Jul 2012
Idenix Pharmaceuticals Announces Restructuring of Development and Commercialization Collaboration With Novartis Pharma AG
Biopharmaceuticals

HSMN NewsFeed - 18 May 2012
Achillion Announces Executive Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Mar 2011
VICTRELIS(TM) (boceprevir), Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control
Biopharmaceuticals

HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Feb 2011
OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Diagnostics FDA

HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 28 Oct 2010
Idenix Pharmaceuticals Announces Ronald C. Renaud, Jr. Named President, Chief Executive Officer and Member of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 10 Aug 2010
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 30 Jul 2010
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jul 2010
Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jun 2010
OraSure Technologies Receives FDA Approval for OraQuick(R) HCV Rapid Test, the First Rapid HCV Test Approved for Sale in the U.S.
Diagnostics FDA

HSMN NewsFeed - 28 May 2010
Roche Diagnostics Receives FDA Approval for Qualitative Anti-HCV Immunoassay Test on Three Analyzer Platforms
Diagnostics FDA

HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Apr 2010
Idera Pharmaceuticals Announces Management Appointments and Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Mar 2010
Ambrilia Biopharma Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2010
InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Feb 2010
Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025
Biopharmaceuticals Licensing

HSMN NewsFeed - 4 Feb 2010
Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA

HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Oct 2009
Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
Diagnostics FDA HIV/AIDS

HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
Biopharmaceuticals Licensing

HSMN NewsFeed - 11 Aug 2009
Chimerix Raises $16.1 Million in Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Aug 2009
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Biopharmaceuticals

HSMN NewsFeed - 27 Jul 2009
Avila Therapeutics, Inc. Closes $30 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 22 Jul 2009
Profectus Biosciences Secures $5M in Series C Venture Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Jul 2009
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2009
Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2009
Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure
Biopharmaceuticals

HSMN NewsFeed - 20 Apr 2009
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
Biopharmaceuticals

HSMN NewsFeed - 24 Mar 2009
Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Mar 2009
Biogel Introduces Polyisoprene (PI) Indicator Underglove
Devices

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2009
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Feb 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Feb 2009
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
Biopharmaceuticals Licensing HIV/AIDS

HSMN NewsFeed - 4 Feb 2009
Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 31 Dec 2008
FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
Diagnostics FDA

HSMN NewsFeed - 4 Dec 2008
European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Nov 2008
Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 28 Oct 2008
OraSure Technologies Files For FDA Approval of OraQuick Rapid Hepatitis C Test
Diagnostics

HSMN NewsFeed - 21 Oct 2008
Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Oct 2008
Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Sep 2008
Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2008
FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
Diagnostics FDA

HSMN NewsFeed - 7 Jul 2008
Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Jul 2008
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Jun 2008
European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Jun 2008
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2008
Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Biopharmaceuticals

HSMN NewsFeed - 19 May 2008
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Apr 2008
Beckman Coulter Acquires Rights to Hepatitis C Virus
Diagnostics Licensing

HSMN NewsFeed - 21 Apr 2008
InterMune Announces Progress on Pirfenidone in IPF
Biopharmaceuticals

HSMN NewsFeed - 17 Apr 2008
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2008
Roche Diagnostics Expands Availability of HCV Immunoassay
Diagnostics Regulatory

HSMN NewsFeed - 27 Mar 2008
Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Mar 2008
Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Mar 2008
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Mar 2008
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
Biopharmaceuticals Litigation

HSMN NewsFeed - 11 Mar 2008
Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Mar 2008
FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Feb 2008
Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
Diagnostics

HSMN NewsFeed - 12 Feb 2008
Cubist Pharmaceuticals Names Steven C. Gilman, Ph.D., as Senior Vice President, Discovery and Non-Clinical Development and Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Feb 2008
Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics

HSMN NewsFeed - 11 Feb 2008
SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
Biopharmaceuticals

HSMN NewsFeed - 14 Jan 2008
Roche responds to announcement of 'IDEAL' hepatitis C trial results
Biopharmaceuticals

HSMN NewsFeed - 10 Jan 2008
Idera Pharmaceuticals Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2007
Cubist Pharmaceuticals Acquires Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Dec 2007
Dr. Robert Karr Resigns from Management Position at Idera
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Dec 2007
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2007
Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 26 Nov 2007
InterMune Buys Out License Agreement for Pirfenidone
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Nov 2007
Genelabs Technologies Regains Exclusive Rights to Prestara(TM) in Japan From Mitsubishi Tanabe Pharma Corporation
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Nov 2007
Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
Biopharmaceuticals

HSMN NewsFeed - 2 Nov 2007
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Biopharmacetuicals

HSMN NewsFeed - 2 Nov 2007
First Studies Demonstrating Greater than Sixty Percent Sustained Viral Response Rates with Half the Standard Treatment Duration in Genotype 1 Chronic Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2007
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2007
Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Sep 2007
Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
Biopharmaceuticals

HSMN NewsFeed - 4 Sep 2007
Study Published in Clinical Cancer Research Confirms Potential Of Peregrine's Bavituximab Combined With Radiation In Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Aug 2007
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Aug 2007
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Biopharmaceuticals

HSMN NewsFeed - 9 Aug 2007
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 2 Aug 2007
Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Jul 2007
Peregrine Pharmaceuticals Adds Pharmaceutical Executive as Head of Business Development for Asia and Europe
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jul 2007
Valopicitabine Development Program Placed on Clinical Hold in the United States
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2007
Abbott Announces Approval of First Fully-Automated Blood Screening Test for Hepatitis C Antibodies
Diagnostics FDA

HSMN NewsFeed - 9 Jul 2007
APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease Announces Completion of Patient Enrollment
Devices Drug Delivery Interventional Cardiology

HSMN NewsFeed - 9 Jul 2007
Peregrine Acquires Worldwide Rights to Novel Anti-Angiogenesis Technology From M. D. Anderson Cancer Center
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Jun 2007
Medical University of South Carolina Initiates New Trial of Cotara(R) in Brain Cancer Patients
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 25 Jun 2007
Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jun 2007
PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Jun 2007
Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon(R)
Biopharmaceuticals

HSMN NewsFeed - 24 May 2007
FDA Approves Gen-Probe's Automated PROCLEIX(R) TIGRIS(R) System to Test Donated Blood With the PROCLEIX ULTRIO(R) Assay
Diagnostics FDA

HSMN NewsFeed - 21 May 2007
PEGASYS(R) Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered ''Cured''
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2007
Data Suggest that PEGASYS(R) May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron(R)
Biopharmaceuticals

HSMN NewsFeed - 21 May 2007
Intercept Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2007
European Union's CHMP Issues Positive Opinion on PEGINTRON(Tm) and REBETOL(R) Combination Therapy for Hepatitis C in Patients Coinfected With HIV
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 Apr 2007
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Apr 2007
Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
Biopharmaceuticals Oncology

HSMN NewsFeed - 11 Apr 2007
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 30 Mar 2007
Peregrine Pharmaceuticals Comments on Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 28 Mar 2007
AVI BioPharma Chairman and CEO Resigns
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2007
Idenix Pharmaceuticals, Inc. Announces Resignation of Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals

HSMN NewsFeed - 8 Mar 2007
Phenomix Completes $55 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 2 Mar 2007
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
Biopharmacetuicals Regulatory

HSMN NewsFeed - 27 Feb 2007
Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon(R) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C Genotypes 2 and 3
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon(R) With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 23 Feb 2007
SEBIVO(R) (telbivudine) Recommended for Approval in European Union as a new Treatment for Patients with Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Feb 2007
TaiGen Appoints Dr. Luke Lin VP of Clinical Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jan 2007
Pharmasset Appoints Michelle Berrey as Chief Medical Officer and William Symonds as Vice President, Clinical Pharmacology
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2007
Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
Roche Diagnostics Submits West Nile Virus Blood Screening Test to FDA
Diagnostics

HSMN NewsFeed - 16 Jan 2007
Peregrine Pharmaceuticals' Tumor Necrosis Therapy Product for the Treatment of Lung Cancer Launched in China
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2007
Presidio Pharmaceuticals Receives Exclusive License to Novel Hepatitis C Virus (HCV) Technology from Stanford University
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Jan 2007
XTL Biopharmaceuticals Announces the In-Licensing of Bicifadine - A Late-Stage Clinical Compound for the Treatment of Neuropathic Pain
Biopharmaceuticals Licensing

HSMN NewsFeed - 15 Jan 2007
Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA
Diagnostics FDA

HSMN NewsFeed - 12 Jan 2007
Peregrine Pharmaceuticals Establishes Wholly Owned Subsidiary in China
Biopharmaceuticals

HSMN NewsFeed - 9 Jan 2007
AVI BioPharma and Eleos Announce Cross-License Agreement for p53 Therapeutics
Biopharmaceuticals Licensing

HSMN NewsFeed - 8 Jan 2007
Idenix Pharmaceuticals, Inc. Announces Appointment of Douglas Mayers, M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jan 2007
Abbott m2000(TM) Molecular Diagnostic Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
Diagnostics Regulatory

HSMN NewsFeed - 4 Jan 2007
Schering-Plough and OraSure Technologies Sign Agreement for Development and Promotion of Rapid Point-of-Care Oral Hepatitis C Test
Diagnostics

HSMN NewsFeed - 4 Jan 2007
Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit
Biopharmaceuticals Diagnostics Litigation

HSMN NewsFeed - 28 Dec 2006
Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Dec 2006
SciClone and Sigma-Tau Complete Enrollment in Phase 3 Triple Therapy Hepatitis C Clinical Trial
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2006
Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon(R) in Combination With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2006
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Dec 2006
Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Norman C. Payson, M.D., Elected to Board of Directors of Idenix Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Nov 2006
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
Biopharmaceuticals Oncology Drug Delivery Licensing

HSMN NewsFeed - 2 Nov 2006
InterMune Closes Collaboration Agreement With Roche
Biopharmaceuticals Licensing

HSMN NewsFeed - 31 Oct 2006
Human Genome Sciences Reports Positive Interim Results of Phase 2 Trials of Albuferon(TM) With Ribavirin in Patients With Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2006
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Idenix Announces New 24-Week Data From A Phase IIb Clinical Trial Of Valopicitabine Plus Pegylated Interferon in Treatment Naive Genotype-1 Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Customizing Treatment with PEGASYS(R) May Improve Chances for Success in Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Roche Oral Polymerase Inhibitor R1626 Shows Strong Antiviral Activity in Chronic Hepatitis C Patients in Early Trial
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2006
Results of PEG-INTRON(R) and REBETOL(R) Study in Retreating Hepatitis C Patients Who Failed Previous Combination Therapy Presented at AASLD
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Idenix Pharmaceuticals Announces Strategic Collaboration To Enhance Hepatitis C Pipeline
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2006
TYZEKA(TM) (telbivudine) Approved by U.S. Food and Drug Administration (FDA) as a New Treatment for Patients with Chronic Hepatitis B
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Oct 2006
Human Genome Sciences Reports Positive Interim Quality-of-Life Data From Phase 2B Trial of Albuferon(TM) with Ribavirin in Treatment-Naive Hepatitis C Patients
Biopharmaceuticals

HSMN NewsFeed - 13 Oct 2006
Roche Advances Oral Polymerase Inhibitor into Phase II Study in Patients with Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 12 Oct 2006
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
Biopharmaceuticals Regulatory Oncology

HSMN NewsFeed - 5 Oct 2006
Gen-Probe Receives FDA Approval for APTIMA(R) HIV-1 RNA Qualitative Assay for Clinical Diagnostic Use
Diagnostics FDA

HSMN NewsFeed - 5 Oct 2006
Specialty Laboratories Launches First Genomic Clinical Laboratory Test to Predict Progression to Liver Fibrosis for Hepatitis C Virus Patients
Diagnostics

HSMN NewsFeed - 4 Oct 2006
Gen-Probe Receives FDA License for PROCLEIX(R) ULTRIO(R) Assay
Diagnostics FDA

HSMN NewsFeed - 4 Oct 2006
Human Genome Sciences Announces Phase 3 Clinical Development Program for Albuferon(TM) in Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 21 Sep 2006
Telbivudine Approved in Switzerland for Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Sep 2006
Jury Finds Abbott Willfully Infringed Innogenetics HCV Patent
Diagnostics Litigation

HSMN NewsFeed - 8 Sep 2006
Bioenvision's Suvus(TM) Lowers Viral Load in Chronic Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 6 Jul 2006
XTL Biopharmaceuticals, Ltd. Announces Managerial Change
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2006
Vertex Pharmaceuticals and Janssen Pharmaceutica, a Johnson & Johnson Company, Form Collaboration to Develop and Commercialize VX-950 for Treatment of Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 May 2006
SciClone Reports Final Results From Second ZADAXIN U.S. Phase 3 Hepatitis C Trial
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Schering-Plough Initiates PEG-INTRON 'PROTECT' Study in Liver Transplant Patients with Recurrent Hepatitis C
Biopharmaceuticals

HSMN NewsFeed - 23 May 2006
Vertex Pharmaceuticals Initiates the First of Two Major Phase II Studies of VX-950 in Treatment-Naive HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
Researchers Report Results for 28-day Phase II Study of VX-950 in Combination with Pegylated Interferon and Ribavirin in Hepatitis C Patients
Biopharmaceuticals

Return to NewsFeed

Additional items found! 291

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 291 additional stories matching:
hepatitis C virus
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.